Similarly, our metastases data indicate that BMS-345541 treatment inhibits breast cancer metastases in mice by inhibiting GD2+ BCSCs, suggesting a critical role of NFκB signaling in breast cancer metastasis. The gene discussed is NFKB1; the disease is breast carcinoma.